|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
LC|n 2020183448
(VIAF cluster)
(Authority/Source Record)
|
|
005
|
|
|
20200515054713.0 |
|
008
|
|
|
200514n| azannaabn |n aaa |
|
003
|
|
|
LC |
|
035
|
|
|
‡a
(LC)11351786
|
|
010
|
|
|
‡a
n 2020183448
|
|
035
|
|
|
‡a
(DNLM)1855201
|
|
035
|
|
|
‡a
(DLC)11353735
|
|
035
|
|
|
‡a
(DLC)n 2020183448
|
|
040
|
|
|
‡a
DNLM
‡b
eng
‡e
rda
‡c
DNLM
|
|
100
|
1 |
|
‡a
Fang, Liang,
‡c
Ph. D.
|
|
368
|
|
|
‡d
Ph. D.
|
|
670
|
|
|
‡a
Statistical methods in biomarker and early clinical development, 2019:
‡b
title page (Liang Fang) t.p. verso (MyoKardia Inc., South San Francisco, CA, USA)
|
|
670
|
|
|
‡a
Bay Area Biotech-Pharma Statistics Workshop web site, May 12, 2020
‡b
(Liang Fang, Ph.D.; Liang is the founding president of BBSW. He is currently the head of Biostatistics in MyoKardia Inc.)
‡u
https://www.bbsw.org/board-and-advisory
|
|
919
|
|
|
‡a
statisticalmethodsinbiomarkerandearlyclinicaldevelopment
‡A
Statistical methods in biomarker and early clinical development, 2019:
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2019
‡9
1
|
|
996
|
|
|
‡2
ISNI|000000007693656X
|
|
996
|
|
|
‡2
SUDOC|241714060
|
|
996
|
|
|
‡2
SUDOC|18100075X
|
|
996
|
|
|
‡2
DNB|1225416833
|
|
996
|
|
|
‡2
WKP|Q53143468
|
|
996
|
|
|
‡2
WKP|Q19855910
|
|
996
|
|
|
‡2
WKP|Q114405869
|
|
996
|
|
|
‡2
WKP|Q92137251
|
|
996
|
|
|
‡2
CYT|AC000207949
|
|
996
|
|
|
‡2
WKP|Q92870255
|
|
996
|
|
|
‡2
DNB|1055780092
|
|
996
|
|
|
‡2
DNB|1038860377
|
|
996
|
|
|
‡2
WKP|Q14565232
|
|
996
|
|
|
‡2
ISNI|0000000064103528
|
|
996
|
|
|
‡2
ISNI|0000000064293667
|
|
996
|
|
|
‡2
WKP|Q80089530
|
|
996
|
|
|
‡2
WKP|Q45631360
|
|
996
|
|
|
‡2
WKP|Q96612718
|
|
996
|
|
|
‡2
ISNI|0000000114215705
|
|
996
|
|
|
‡2
WKP|Q90375481
|
|
996
|
|
|
‡2
DNB|1312342382
|
|
996
|
|
|
‡2
WKP|Q124727954
|
|
996
|
|
|
‡2
WKP|Q104138692
|
|
996
|
|
|
‡2
WKP|Q95989560
|
|
996
|
|
|
‡2
CYT|AC000207950
|
|
996
|
|
|
‡2
ISNI|0000000063703492
|
|
996
|
|
|
‡2
RERO|A003230818
|
|
996
|
|
|
‡2
WKP|Q97884444
|
|
996
|
|
|
‡2
DNB|111698461X
|
|
996
|
|
|
‡2
WKP|Q94950553
|
|
996
|
|
|
‡2
PLWABN|9813280904505606
|
|
996
|
|
|
‡2
WKP|Q88322948
|
|
996
|
|
|
‡2
ISNI|0000000048035158
|
|
996
|
|
|
‡2
DNB|14062841X
|
|
996
|
|
|
‡2
ISNI|0000000063749044
|
|
996
|
|
|
‡2
ISNI|0000000496642832
|
|
996
|
|
|
‡2
DNB|1036633667
|
|
996
|
|
|
‡2
DNB|1038719372
|
|
996
|
|
|
‡2
WKP|Q131168623
|
|
996
|
|
|
‡2
ISNI|0000000064169180
|
|
996
|
|
|
‡2
J9U|987012501781105171
|
|
996
|
|
|
‡2
NII|DA11668706
|
|
996
|
|
|
‡2
WKP|Q130964070
|
|
996
|
|
|
‡2
WKP|Q45474321
|
|
996
|
|
|
‡2
WKP|Q18118628
|
|
996
|
|
|
‡2
N6I|vtls000301960
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Fang, Liang
‡c
Ph. D
‡2
ISNI|0000000496642832
‡3
exact name
|
